Beijing CoSci Med-Tech Co.,Ltd

Beijing CoSci Med-Tech Co.,Ltd is a pioneering pharmaceutical research company and innovative high-tech enterprise based in Beijing Zhongguancun Science and Technology Park. Specializing in preclinical, clinical, and early-phase drug development, as well as industrialization research, the company boasts a team of seasoned professionals, scientific experts, and successful business executives.

CoSci Med-Tech is at the forefront of sustained-release, controlled-release, and orally disintegrating techniques in China, which underpin its proprietary products. Since its establishment, the company has delivered efficient development programs and promising market prospects for drugs and nutritional supplements. By 2009, CoSci Med-Tech had made significant strides in R&D, introducing new products and technologies, and forging strategic partnerships. The company achieved the registration of the first pharmaceutical preparations from China in the EU and developed 80 drug products, filed 107 patents, with 53 granted, and 6 PCT applications. CoSci Med-Tech supports clients from development and registration to marketing across various pharmacologic agents, collaborating with leading pharmaceutical enterprises both domestically and internationally. By offering tailored programs to meet diverse needs and situations, the company aims to assist foreign businesses in introducing new products and technologies into China, undertake commission processing, and access the vast Chinese market. Simultaneously, it helps Chinese businesses export products and technologies abroad. Committed to the principles of science and technology, honesty, cooperation, and development, the company seeks active collaboration with research institutes, universities, pharmaceutical enterprises, and medicine distributors worldwide to contribute to global health.